Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

711
Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
711
Hypertension I: Introduction01:28

Hypertension I: Introduction

1.2K
Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
1.2K
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

1.4K
Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
1.4K
Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

831
Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
831
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

4.8K
Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
4.8K
Hypertension V: Nursing Management01:23

Hypertension V: Nursing Management

645
The nursing management of hypertension involves accurately assessing symptoms, making a comprehensive nursing diagnosis, collaborating with patients to set goals, and implementing targeted interventions to mitigate the condition's impact and improve patient well-being.Comprehensive AssessmentThe initial step in nursing care for hypertension involves a thorough patient assessment. It includes evaluating symptoms such as headaches, dizziness, blurred vision, and previous hypertension episodes.
645

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The mediating role of power distance and fear of negative evaluation in medical error under-reporting across surgical and internal divisions: a multicenter cross-sectional survey in Turkey.

BMC health services research·2026
Same author

Polypharmacy and associated factors in patients with type 2 diabetes: a nationwide cross-sectional study (TEMD-2 polypharmacy study).

Postgraduate medicine·2026
Same author

Evaluation of the Knowledge Level and Attitudes of Family Physicians Regarding Circumcision: A Cross-sectional Study.

Rwanda journal of medicine and health sciences·2026
Same author

Reply to the Letter to the Editor: Two Overlooked Issues in Hypertension Management: Risk Thresholds and Obesity Integration.

Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir·2026
Same author

Suboptimal LDL-Cholesterol Control Under the 2019 ESC/EAS Dyslipidemia Guidelines: Results From the Nationwide TEMD-2 Study in Type 2 Diabetes.

Diabetes, obesity & metabolism·2026
Same author

Real-World Comparison of Short-Term Adverse Events, Treatment Persistence, and Efficacy of Semaglutide and Tirzepatide: A Nationwide Multicenter Study.

Obesity facts·2026
Same journal

Endothelin-Dependent Myocardial Dysfunction in an Experimental Endotoxic Shock Model.

Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir·2026
Same journal

Subclinical Cardiac Dysfunction in Children with Iron Deficiency Anemia Assessed by Tissue Doppler and Speckle-Tracking Echocardiography-Uncorrected Proof.

Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir·2026
Same journal

Reply to the Letter to the Editor: A Critical Appraisal of Drug-Coated Balloon Use in STEMI: Biological Context, Cohort Heterogeneity, and Strategy Definition.

Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir·2026
Same journal

Reply to the Letter to the Editor: Assessing the Predictive Value of Kolmogorov-Arnold Networks for the No-Reflow Phenomenon in ST-Segment Elevation Myocardial Infarction: A Comparative Machine Learning Study.

Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir·2026
Same journal

High Discriminative Performance Without Clinical Readiness: Methodological Gaps in Machine Learning-Based Prediction of the No-Reflow Phenomenon in ST-Segment Elevation Myocardial Infarction.

Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir·2026
Same journal

A Critical Appraisal of Drug-Coated Balloon Use in STEMI: Biological Context, Cohort Heterogeneity, and Strategy Definition.

Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir·2026
See all related articles

Related Experiment Video

Updated: Mar 27, 2026

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
07:51

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis

Published on: September 26, 2018

8.2K

[The Turkish Hypertension Consensus Report 2025].

Bülent Özin1, Bülent Altun2, Fazıl Mustafa Cesur3

  • 1Department of Internal Medicine, Division of Cardiology, Başkent University Faculty of Medicine, Ankara, Türkiye.

Turk Kardiyoloji Dernegi Arsivi : Turk Kardiyoloji Derneginin Yayin Organidir
|March 25, 2026
PubMed
Summary
This summary is machine-generated.

The 2025 Turkish Hypertension Consensus Report updates hypertension definitions and introduces age- and frailty-based treatment targets. It emphasizes combination therapy and includes new guidance on resistant hypertension and orthostatic hypotension.

More Related Videos

Author Spotlight: Exploring Huotan Jiedu Tongluo Decoction as an Antihypertensive Drug
05:57

Author Spotlight: Exploring Huotan Jiedu Tongluo Decoction as an Antihypertensive Drug

Published on: May 17, 2024

1.3K
Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion
08:35

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion

Published on: May 26, 2022

4.4K

Related Experiment Videos

Last Updated: Mar 27, 2026

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
07:51

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis

Published on: September 26, 2018

8.2K
Author Spotlight: Exploring Huotan Jiedu Tongluo Decoction as an Antihypertensive Drug
05:57

Author Spotlight: Exploring Huotan Jiedu Tongluo Decoction as an Antihypertensive Drug

Published on: May 17, 2024

1.3K
Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion
08:35

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion

Published on: May 26, 2022

4.4K

Area of Science:

  • Cardiology
  • Nephrology
  • Geriatrics
  • Family Medicine

Background:

  • The Turkish Hypertension Consensus Report (THCR) was updated to address recent changes in hypertension definitions and guidelines.
  • New societies, including Geriatrics and Family Physicians, contributed to the 2025 update.
  • Evolving professional guidelines necessitated a revision of practical clinical guidance.

Purpose of the Study:

  • To provide updated, practical guidance for diagnosing and managing hypertension in outpatient settings.
  • To incorporate new evidence and recommendations into clinical practice.
  • To define new blood pressure thresholds and cardiovascular risk scoring systems.

Main Methods:

  • The report defines normal, elevated, and hypertensive blood pressure stages (Stage 1 and 2).
  • It emphasizes home and ambulatory blood pressure monitoring alongside office measurements.
  • Age- and frailty-based treatment thresholds and targets were established, independent of comorbidities.

Main Results:

  • Normal blood pressure is defined as <120/<80 mmHg; elevated blood pressure as 120-139/80-89 mmHg; hypertension as ≥140/≥90 mmHg.
  • Combination antihypertensive therapy is recommended immediately for Stage 1 and 2 hypertension.
  • A stepwise combination treatment algorithm using ACEIs, ARBs, CCBs, diuretics, and MRAs is provided.

Conclusions:

  • The 2025 THCR provides comprehensive updates on hypertension diagnosis and management.
  • New sections address frailty assessment, resistant hypertension, and orthostatic hypotension.
  • Individualized, patient-centered care remains essential for effective hypertension management.